Ali Krisht, MD
Neurological Surgery · Sherwood, ARNPI 1043300528
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,250 of the $15,004 with a category attached, or 68.3%. Integra Lifesciences Corporation accounts for 94.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $13,622 and has fallen 99.7% since, to $36 in 2025.
Across 20 payments — averaging $750.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$14K
- Stryker$500
- Si-bone, Inc.$125
- Zimmer Biomet$114
- Baxter Healthcare$53
- Carl Zeiss Meditec USA, Inc.$36
- plus $49 from 3 others
What the payments were for
- Consulting fees$10,25068%
- Travel & lodging$4,09127%
- Food & beverage$6634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 10 | $14,126 |
| Stryker | 1 | $500 |
| Si-bone, Inc. | 1 | $125 |
| Zimmer Biomet | 2 | $114 |
| Baxter Healthcare | 2 | $53 |
| Carl Zeiss Meditec USA, Inc. | 1 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Smith+Nephew | 1 | $15 |
| Elutia, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$21,655
- OMNIGRAFT$9,500
- INTEGRA DERMAL REGENERATION TEMPLATE$4,052
- PRIMATRIX$4,052
- BIOFIX$361
- CYTAL$286
- iFuse Implant$125
- BIODRESTORE$111
- MEDIHONEY$111
- BIODOPTIX$111
- BIODFACTOR$111
- 1.5mm Neuro$108
How this compares
$15,004 in reported general payments places this provider in the 80th percentile of 64 neurological surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $6,991 |
| Phenytoin Sodium Extended | 102 | $1,957 |
| Levetiracetam | 55 | $1,160 |
| Desmopressin Acetate | 17 | $849 |
| Hydrocortisone | 20 | $847 |
| Cabergoline | 13 | $622 |
| Carbamazepine | 25 | $563 |
| Diazepam | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Sherwood
- Andrew RockSherwood$5K
- Hossam YoussefSherwood$4K
- Khaled KrishtSherwood$3K
- Tarek AbuelemSherwood$2K
- Stylianos RammosSherwood$1K
- Jaafar BasmaSherwood$299
- Adedamola AdepojuSherwood$274
- Erika PetersenLittle Rock$663K
- James BlankenshipFayetteville$217K
- Keith NorvillHot Springs$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.